Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
← catalyst calendarNCT07247279 · readout in 1,230 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
450estimated
Sites
7
Country
Russia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-12-23 | actual | When the study began enrolling |
| Primary completion | 2029-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2025-11-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Rare Diseases
- Generalized Myasthenia Gravis (gMG)
Primary outcomes
what the primary-completion date above is the date OFAge at baseline (years)
measured Baseline (Month 0; at informed consent and enrollment)
Age at gMG diagnosis (years)
measured Baseline (retrospective abstraction at Month 0)
Sex and ethnicity distribution
measured Baseline (Month 0)
Body Mass Index (BMI)
measured Baseline (Month 0; last available measurements closest to ICF signing)
Disease duration (days)
measured Baseline (Month 0)
Clinical symptom profile of gMG
measured Baseline (Month 0)
Comorbidity profile
measured Baseline (Month 0)
Number and proportion of patients with gMG-related hospitalizations
measured Retrospective period from gMG diagnosis to Baseline (Month 0)
Duration of gMG-related hospitalizations (days)
measured Retrospective period from gMG diagnosis to Baseline (Month 0)
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed